A novel subset of B7-H3+CD14+HLA-DFT−/low myeloid-derived suppressor cells are associated with progression of human NSCLC

OncoImmunology

Volumn 4, Issue 2, 2015, Pages 1-12

  Zhang, Guangbo ^a   Huang, Haitao ^a,b   Zhu, Yibei ^a   Yu, Gehua ^a   Gao, Xin ^a   Xu, Yunyun ^a   Liu, Cuiping ^a   Hou, Jianquan ^a   Zhang, Xueguang ^a  

^a SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

B7 H3; MDSC; Non small cell lung cancer; Treg; Tumor microenvironment

Indexed keywords

B7 ANTIGEN; B7 H3 ANTIGEN; CD14 ANTIGEN; CD3 ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER STAGING; CD4+ T LYMPHOCYTE; CELL SUSPENSION; CONTROLLED STUDY; CYTOFLUOROMETRY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MALE; METASTASIS; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NON SMALL CELL LUNG CANCER; NONHUMAN; RECURRENCE FREE SURVIVAL; SUPPRESSOR CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 84954537253     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/2162402X.2014.977164     Document Type: Article

References (25)

1. Gabrilovich DI, Nagaraj S. Myeloid-derived, suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162-74; PMID: 19197294; http://dx.doi.org/10.1038/nri2506
2. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008; 181:5791-802; PMID: 18832739; http://dx.doi.org/10.4049/jimmunol.181.8.5791
3. Zhu B, Kennedy JK, Wang Y, Sandoval-Garcia C, Cao L, Xiao S, Wu C, Elyaman W, Khoury SJ. Plasticity of Ly-6C(hi) myeloid cells in T cell regulation. J Immunol 2011; 187:2418-32; PMID:21824867; http://dx.doi.org/10.4049/jimmunol.l100403
4. Brandau S, Moses K, Lang S. The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: Cousins, siblings or twins? Semin Cancer Biol 2013; 23:171-82; PMID:23459190; http://dx.doi.org/10.1016/j.semcancer.2013.02.007
5. Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signoretti S, Zabaleta J, McDermott D, Quiceno D, Youmans A, O’Neill A, et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res 2005; 65:3044-8; PMID: 15 833831
6. −/CD 15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer. J. Cancer Res. Clin. Oncol. 2010; 136:35-45.
7. Filipazzi P, Valenti R, Huber V, Pilla L, Canese P, Iero M, Castelli C, Mariani L, Parmiani G, Rivoltini L. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macro phage colony-stim- ulation factor-based antitumor vaccine. J Clin Oncol 2007; 25:2546-53; PMID: 17577033; http://dx.doi.org/10.1200/JC0.2006.08.5829
8. Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Kruger C, Manns MP, Greten TF, Korangy F. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25 (+)Foxp3(+) T cells. Gastroenterology 2008;135:234-43; PMID: 18485901; http://dx.doi.org/10.1053/j-gastro.2008.03.020
9. Lin Y, Gustafson MP, Bulur PA, Gastineau DA, Witzig TE, Dietz AB. Immunosuppressive CD14+HLA-DR (low)/- monocytes in B-cell non-Hodgkin lymphoma. Blood 2011;117:872-81; PMID:21063024; http://dx.doi.org/10.1182/blood-2010-05-283820
10. Corzo CA, Condamine T, Lu L, Cotter MJ, Youn JI, Cheng P, Cho HI, Celis E, Quiceno DG, Padhya T, et al. HIF-1 alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med 2010; 207:2439-53; PMID: 20876310; http://dx.doi.org/10.1084/jem.20100587
11. Gros A, Turcotte S, Wunderlich JR, Ahmadzadeh M, Dudley ME, Rosenberg SA. Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma. Clin Cancer Res 2012; 18:5212-5223; PMID:22837179; http://dx.doi.org/10.1158/1078-0432.CCR-12-1108
12. Chapoval Al, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K, et al. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol 2001; 2:269-74; PMID: 11224528; http://dx.doi.org/10.1038/85339
13. Prasad DV, Nguyen T, Li Z, Yang Y, Duong J, Wang Y, Dong C. Murine B7-H3 Is a Negative Regulator of T Cells. J Immunol 2004; 173:2500-6; PMID: 15294965; http://dx.doi.org/10.4049/jimmunol.173.4.2500
14. Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Yamazaki T, Akiba H, Okumura K, Yagita H, Ueno H. B7-H3 regulates the development of experimental allergic conjunctivitis in mice. Immunol Lett 2007; 113:52-7; PMID: 17825429; http://dx.doi.org/10.1016/j.imlet.2007.07.011
15. Suh WK, Gajewska BU, Okada H, Gronski MA, Bertram EM, Dawicki W, Duncan GS, Bukczynski J, Plyte S, Elia A. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat Immunol 2003; 4:899-06; PMID: 12925852; http://dx.doi.org/10.1038/ni967
16. Lemke D, Pfenning PN, Sahm F, Klein AC, Kempf T, Warnken U, Schnolzer M, Tudoran R, Weller M, Platten M, et al. Costimulatory Protein 4lgB7H3 Drives the Malignant Phenotype of Glioblastoma by Mediating Immune Escape and Invasiveness. Clin Cancer Res 2012; 18:105-17; PMID:22080438; http://dx.doi.org/10.1158/1078-0432.CCR-11-0880
17. Arigami T, Narita N, Mizuno R, Nguyen L, Ye X, Chung A, Giuliano AE, Hoon DS. B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis. Annals of surgery 2010; 252:1044-51; PMID:21107115; http://dx.doi.org/10.1097/SLA.0b013e3181fl939d
18. Hofmeyer KA, Ray A, Zang X. The contrasting role of B7-H3. Proc Natl Acad Sci U S A 2008;105:10277-8; PMID:18650376; http://dx.doi.org/10.1073/pnas.0805458105
19. Gao X, Zhu Y, Li G, Huang H, Zhang G, Wang F, Sun J, Yang Q, Zhang X, Lu B. TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and. Is Associated with Lung Cancer Progression. PLoS ONE. 2012; 7(2): e30676; PMID=22363469; http://dx.doi.org/10.1371/journal.pone.0030676
20. Ma G, Pan PY, Eisenstein S, Divino CM, Lowell CA, Takai T, Chen SH. Paired immunoglobin-like receptor- B regulates the suppressive function and fate of myeloid- derived suppressor cells. Immunity 2011; 34:385-95; PMID :2137664l http://dx.doi.Org/10.1016/j.immuni.2011.02.004
21. Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin- 13. Cancer Immunol Immunother 2011; 60:1419-30; PMID:21644036; http://dx.doi.org/10.1007/s00262-011-1028-0
22. Poschke I, Mougiakakos D, Hansson J, Masucci GV, Kiessling R. Immature immunosuppressive CDl4+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC- sign. Cancer Res 2010; 70:4335-45; PMID: 20484028; http://dx.doi.org/10.1158/0008-5472.CAN-09-3767
23. Pan PY, Ma G, Weber KJ, Ozao-Choy J, Wang G, Yin B, Chen SH. Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res 2010; 70:99-108; PMID: 19996287; http://dx.doi.org/10.1158/0008-5472.CAN-09-1882
24. Fujimura T, Ring S, Umansky V, Mahnke K, Enk AH. Regulatory T Cells Stimulate B7-H1 Expression in Myeloid-Derived Suppressor Cells in ret Melanomas. J Invest Dermatol 2012; 132:1239-46; PMID: 22189788; http://dx.doi.org/10.1038/jid.2011.416
25. Huang B, Pan PY, Li Q, Sato Al, Levy DE, Bromberg J, Divino CM, Chen SH. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 2006; 66:1123-31; PMID: 16424049; http://dx.doi.org/10.1158/0008-5472.CAN-05-1299